Unable to hoodwink the people of Liberia about the risks of the Ebola vaccine trials, the snake oil salesmen are shuffling over to Guinea for a second shot.

“Now that Ebola is not the risk it was to Liberia several months ago, the trial is unlikely to continue according to the original plan.

“It doesn’t make sense to expand the study in Liberia when there are fortunately no new infections occurring,” says Dr. H. Clifford Lane, the deputy director for clinical research and special projects at the National Institute of Allergy and Infectious Diseases.

“We need to be sure we enroll a population that is still at risk for Ebola virus infection so we can show the protective effect of either or both of the vaccines,” writes Time.

http://time.com/3743945/ebola-vaccine-trials/

In spite of a significant cash inducement to entrap impoverished locals, few in Liberia were tempted to put their health on the line.

The appeal of a government minister to step up and take the shot was dismissed by angry callers to a talk show who asked why no high ranking government officials had taken the Ebola jab.

The New York Times understated report on the public scepticism in Liberia gives welcome confirmation of just how fast news travels today to even the most remote parts of the world.

http://www.ny#times.com/2015/03/14/world/africa/ebola-vaccine-resea...

Guinea could prove to be another kettle of fish altogether for the peddlers of snake oil, who are also eyeing Sierra Leone.

“In September, eight people were killed with machetes and stones in the village of Womey when they arrived as part of an “Ebola Sensitization” effort.

According to the WHO, during one recent week, residents of 27 towns in Guinea resisted Ebola-eradication efforts.”

http://www.washingtonpost.com/news/to-your-health/wp/2015/03/13/res...